Efficacy News and Research

RSS

Protein marker unveiled for identifying blood vessel repair cells

Researchers have discovered a protein marker to help identify cells able to repopulate in patients with damaged blood vessels.

7 May 2024

AI-driven model identifies potent cancer-killing immune cells for personalized immunotherapy

Using artificial intelligence, Ludwig Cancer Research scientists have developed a powerful predictive model for identifying the most potent cancer killing immune cells for use in cancer immunotherapies.

7 May 2024

UCLA Health symposium explores the fusion of psychedelic therapies and ecological medicine

UCLA Health is set to host a unique symposium this week to explore the evolving research in psychedelic therapies and how combining it with reconnection to natural world could help to amplify their mental health benefits.

7 May 2024

Hemp seed protein shows promise in lowering blood pressure

A study in The American Journal of Clinical Nutrition shows that hemp seed protein and its bioactive peptide can significantly lower blood pressure in mildly hypertensive adults, offering a potential dietary intervention for managing hypertension.

7 May 2024

Mindfulness training reduces dropout rates and relapses in opioid addiction treatment

Supplementing standard opioid addiction treatment with Mindfulness Oriented Recovery Enhancement (MORE) -; an intervention that incorporates mindfulness training, savoring skills, and cognitive reappraisal -; cuts program dropout rates by 59 percent and relapses by 42 percent, according to Rutgers-led research.

6 May 2024

MedStar Washington Hospital Center enrolls first U.S. patient in gene-editing therapy trial for heart disease

The first U.S. heart patient involved in a study for a new gene-editing therapy directly infused inside the body has successfully been enrolled at MedStar Washington Hospital Center.

6 May 2024

CRISPR gene editing shows promise for treating individuals with a form of inherited blindness

Results from a groundbreaking clinical trial of CRISPR gene editing in 14 individuals with a form of inherited blindness show that the treatment is safe and led to measurable improvements in 11 of the participants treated.

6 May 2024

Study sheds light on the promising role of virtual reality in treating depression

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD).

6 May 2024

Durable lymph-node expansion improves vaccine responses against tumors

Each one of us has around 600 lymph nodes (LNs) – small, bean-shaped organs that house various types of blood cells and filter lymph fluid – scattered throughout our bodies.

6 May 2024

Modified sugar molecules boost stem cell therapy for brain repair after cardiac arrest

Researchers at the University of Maryland School of Medicine (UMSOM) have identified an innovation in stem cell therapy to regenerate neural cells in the brain after cardiac arrest in an animal model.

6 May 2024

New influenza vaccine strategies aim to enhance protection with T-cell responses

A recent review highlights the need for innovative influenza vaccines that combine T-cell and antibody responses to enhance protection across multiple strains and seasons.

6 May 2024

Wild Sumatran orangutan uses medicinal plant to treat facial wound

Researchers documented the first observed case of a wild Sumatran orangutan actively treating a wound using a medicinal plant, offering insights into the origins of self-medication in non-human species.

5 May 2024

New study shows age, sex, race crucial for predicting mortality risks in older adults

Study finds that the LS7 and LE8 scores predict all-cause and cardiovascular mortality with similar efficacy in the overall U.S. population. However, the PCE score is better at predicting mortality in individuals aged 40 to 79.

5 May 2024

NK cells' role in cancer therapy resistance unveiled

Activated T cells that carry a certain marker protein on their surface are controlled by natural killer (NK) cells, another cell type of the immune system.

3 May 2024

Novel dual-action thrombectomy device shows promise in treating acute pulmonary embolism

Late-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effective and safe in treating acute pulmonary embolism (PE).

3 May 2024

Study supports the consideration of 177Lu-PSMA-617 as new standard treatment for metastatic prostate cancer

In a follow-on analysis of results from the phase 3 PSMAfore study, clinical investigators from Dana-Farber and elsewhere found that clinical outcomes consistently favored 177Lu-PSMA-617 over a change from one androgen receptor pathway inhibitor (ARPI) to another, regardless of which ARPI patients received first.

3 May 2024

APEX-AV trial shows positive results for catheter-directed thrombectomy in acute pulmonary embolism

New data from the Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AX) demonstrated that catheter-directed mechanical thrombectomy is safe and effective in patients with acute intermediate-risk pulmonary embolism (PE) with significant improvement in the right ventricle (RV) function and minimal major adverse events.

3 May 2024

Transparent nanostructured copper surface: A breakthrough in antimicrobial touch screen technology

The interest in antimicrobial solutions for personal and multi-user touch screens, such as tablets and mobile devices, has grown in recent years.

3 May 2024

Gyros Protein Technologies introduces Gyrolab Generic Rodent ADA Kit Reagents to support preclinical immunogenicity assessment

...

From Gyros Protein Technologies AB 3 May 2024

Long-term impact of online school-based mental health and substance abuse program: A 72-month study in Australia

The long-term effectiveness of four school-based, online interventions for preventing mental health and substance use.

3 May 2024

Efficacy News and Research

Protein marker unveiled for identifying blood vessel repair cells

AI-driven model identifies potent cancer-killing immune cells for personalized immunotherapy

UCLA Health symposium explores the fusion of psychedelic therapies and ecological medicine

Hemp seed protein shows promise in lowering blood pressure

Mindfulness training reduces dropout rates and relapses in opioid addiction treatment

MedStar Washington Hospital Center enrolls first U.S. patient in gene-editing therapy trial for heart disease

CRISPR gene editing shows promise for treating individuals with a form of inherited blindness

Study sheds light on the promising role of virtual reality in treating depression

Durable lymph-node expansion improves vaccine responses against tumors

Modified sugar molecules boost stem cell therapy for brain repair after cardiac arrest

New influenza vaccine strategies aim to enhance protection with T-cell responses

Wild Sumatran orangutan uses medicinal plant to treat facial wound

New study shows age, sex, race crucial for predicting mortality risks in older adults

NK cells' role in cancer therapy resistance unveiled

Novel dual-action thrombectomy device shows promise in treating acute pulmonary embolism

Study supports the consideration of 177Lu-PSMA-617 as new standard treatment for metastatic prostate cancer

APEX-AV trial shows positive results for catheter-directed thrombectomy in acute pulmonary embolism

Transparent nanostructured copper surface: A breakthrough in antimicrobial touch screen technology

Gyros Protein Technologies introduces Gyrolab Generic Rodent ADA Kit Reagents to support preclinical immunogenicity assessment

Long-term impact of online school-based mental health and substance abuse program: A 72-month study in Australia

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News